Home › Funds › Third Point › SPRY
Third Point position in SPRY
ARS PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)1.00M sh
Reported value held$8.01M
Portfolio Weight0.19%
First reportedQ4 2025
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 556.24K | $6.48M | New |
| Q1 2026 | 1.00M | $8.03M | Add |
| Q2 2026 | 1.00M | $8.01M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SPRY
- BlackRock Inc 5.31M sh · $42.54M · Q2 2026
- Vanguard Group 3.51M sh · $40.88M · Q4 2025
- Capital World Investors 2.75M sh · $22.07M · Q2 2026
- Millennium Management 2.52M sh · $20.19M · Q2 2026
- UBS Group AG 1.94M sh · $15.54M · Q2 2026
- Geode Capital Management 1.70M sh · $13.61M · Q2 2026
- Citadel Advisors 566.56K sh · $4.54M · Q2 2026
- Charles Schwab Investment Management 551.42K sh · $4.42M · Q2 2026
- Northern Trust Corp 549.06K sh · $4.40M · Q2 2026
- Bank of America Corp 463.26K sh · $3.71M · Q2 2026
- Fidelity International (FIL) 455.57K sh · $3.65M · Q2 2026